Viking Therapeutics

VKTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.997 B

$34.26 +2.88%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$359.6M

Loss-making

Shares outstanding

116,652,937

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#65Parabilis MedicinesPBLS$4.15B
#66Genmab A/SGMAB$4.01B
#67Viking TherapeuticsVKTX$4.00B
#68Tango TherapeuticsTNGX$3.92B
#69Telix PharmaceuticalsTLX$3.90B

Where these numbers come from

Share counts and financials for Viking Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.